Parian Global Management’s NEVRO CORP. NVRO Stock Holding History

Parian Global Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-83,903	Closed	-$8.39M	–	55
2020 Q1	$8.39M	Sell	83,903 -6,097	-7%	-$733K	2.96%	12
2019 Q4	$10.6M	Sell	90,000 -22,708	-20%	-$2.25M	2.38%	13
2019 Q3	$9.69M	Sell	112,708 -38,777	-26%	-$2.93M	4.39%	9
2019 Q2	$9.82M	Buy	+151,485	New	+$9.43M	6.37%	7

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Parian Global Management's NVRO Position: Q2 2020 in Review

Parian Global Management sold out of NEVRO CORP. (NVRO) in Q2 2020, closing a stake of 83,903 shares — an estimated $8.39M sold.

Parian Global Management first reported a position in NVRO in Q2 2019 and held it in 4 quarters. The position peaked at $10.6M in Q4 2019. 202 funds tracked by Wall St. Rank hold NVRO as of Q2 2020.

Parian Global Management reported no remaining NEVRO CORP. position as of Q2 2020 after selling out during the quarter.
Parian Global Management sold 83,903 NEVRO CORP. shares in Q2 2020, an estimated $8.39M.
Parian Global Management first reported a position in NEVRO CORP. in Q2 2019 and held it in 4 quarters.
Parian Global Management's NEVRO CORP. position peaked at $10.6M in Q4 2019.
202 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2020.

Based on Parian Global Management's 13F filing for Q2 2020, filed 14 Aug 2020.